Revenue in the pharmaceuticals market by segment Canada| ��ƽ��

Health, Pharma & Medtech
Pharmaceutical Products & Market

Revenue in the pharmaceuticals market in Canada from 2016 to 2030, by segment (in million U.S. dollars)

Characteristic	Oncology drugs	Anti-diabetes drugs	Anti-rheumatic drugs	Vaccines	Dermatological drugs	Sensory organs drugs	Immunosuppressants	Antiviral drugs	Bronchodilator drugs	Anti-hypertensive drugs
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-

The chart is not accessible to screen readers. Please switch to the table view to access the data.

You need a ��ƽ�� Account for unlimited access

Immediate access to 1m+ statistics
Incl. source references
Download as PNG, PDF, XLS, PPT

Get full access

Already have an account?

Download

Source

Show detailed source information?

Already a member?

Sources

More information

Citation formats

Revenue in the pharmaceuticals market in Canada 2016-2030, by segment

Published by ��ƽ�� Research Department, Oct 30, 2025

In the pharmaceuticals market in Canada in 2024, the oncology drugs segment generated the highest revenue, reaching approximately ** U.S. dollars. The anti-diabetes drugs segment ranked second with around ** U.S. dollars, while vaccines followed with about ** U.S. dollars.